NTM
Showing 26 - 50 of 133
Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
Recruiting
- Cystic Fibrosis
-
Birmingham, Alabama
- +19 more
May 11, 2021
NTM Disease In CysTic Fibrosis
Recruiting
- Cystic Fibrosis
-
Birmingham, Alabama
- +19 more
May 11, 2021
Study of Mycobacterial Infections
Recruiting
- Mycobacterium Infections
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Healthcare-associated Links in Transmission of Nontuberculous
Recruiting
- Cystic Fibrosis
- Nontuberculous Mycobacterium Infection
- Epidemiologic investigation
-
Denver, ColoradoNational Jewish Health
Apr 6, 2022
NUTRITIONAL ASSESSMENT IN NON-TUBERCULOUS MYCOBACTERIA PULMONARY
Recruiting
- Non-Tuberculous Mycobacterial Pneumonia
-
Monza, MB, ItalySan Gerardo Hospital
Oct 21, 2022
NTM Lung Infection Due to MAC Trial (LAI 590 mg, Multi-drug regimen)
Completed
- NTM Lung Infection Due to MAC
- LAI 590 mg
- Multi-drug regimen
- (no location specified)
Jan 21, 2020
Nontuberculous Mycobacterial Diseases Trial in Nijmegen (Clofazimine)
Recruiting
- Nontuberculous Mycobacterial Diseases
-
Nijmegen, Gelderland, NetherlandsRadboud university medical center
Sep 9, 2022
Multiplex PCR -Microarray-based Assay in Detection of
Completed
- Tuberculosis
- Non-Tuberculous Mycobacterial Pneumonia
- VereMTB
-
Sha Tin, Hong KongPrince of Wales Hospital
Aug 7, 2022
Performance Evaluation of the VIDAS TB-IGRA Assay.
Completed
- Active Tuberculosis
- +2 more
- Blood draw and IGRA test
-
Palo Alto, California
- +23 more
Jul 14, 2021
Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)
Completed
- Mycobacterium Infections, Nontuberculous
- LAI (Liposomal Amikacin for Inhalation) 590 mg
- (no location specified)
Apr 22, 2020
Drug Exposure and Minimum Inhibitory Concentration in Treatment
Not yet recruiting
- Mycobacterium Avium Complex
- +3 more
- Drug exposure
-
Shanghai, ChinaShanghai Pulmonary Hospital
Apr 10, 2023
Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,
Recruiting
- Mycobacterium Avium Complex
- Nontuberculous Mycobacterium Infection
- Azithromycin
- +2 more
-
Loma Linda, California
- +26 more
Jan 18, 2023
Cross-sectional Characterization of Idiopathic Bronchiectasis
Completed
- Infection
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
MAC Lung Disease Trial in United States (Epetraborole, Placebo)
Recruiting
- MAC Lung Disease
- Treatment Refractory MAC Lung Disease
- Epetraborole
- Placebo
-
Birmingham, Alabama
- +40 more
Jan 31, 2023
Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict
Active, not recruiting
- Acute Kidney Injury
- +2 more
- Acute kidney Injury due to nephrotoxic medications in the NICU
-
Birmingham, Alabama
- +1 more
Jan 19, 2023
PK and PD of Antibiotics for Treatment of Mycobacterium
Not yet recruiting
- Nontuberculous Mycobacterial Pulmonary Infection
- Measuring PK and PD indices in patients who receive conventional treatment
- (no location specified)
Dec 22, 2022
Mycobacterial and Opportunistic Infections in HIV-Negative Thai
Active, not recruiting
- Non-Tuberculous Mycobacteria
- +2 more
-
Taiwan, ChinaNational Taiwan University
Aug 18, 2022
Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical
Recruiting
- Nontuberculous Mycobacterial Lung Disease
-
Charlottesville, VirginiaUniversity of Virginia, Division of Infectious Disease
May 16, 2022
Respiratory Tract Infections, Corona Virus Infection Trial in Vancouver (Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for
Terminated
- Respiratory Tract Infections
- Corona Virus Infection
- Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation
-
Vancouver, British Columbia, CanadaNitric Solutions-Mobile Unit
Jul 12, 2021
Non - Tuberculosis Mycobacteria Lung Disease Trial in Shanghai (Genotype detected through GenSeizer high-throughput gene capture
Unknown status
- Non - Tuberculosis Mycobacteria Lung Disease
- Genotype detected through GenSeizer high-throughput gene capture technology
-
Shanghai, ChinaHaiqing Chu
Sep 17, 2019
Tuberculosis, Latent Tuberculosis, Nontuberculous Mycobacterium Infection Trial in Busan (therapeutic drug monitoring(TDM))
Recruiting
- Tuberculosis
- +2 more
- therapeutic drug monitoring(TDM)
-
Busan, Korea, Republic ofInje University Busan Paik Hoapital Clinical Trial Center
Mar 6, 2022
Tuberculosis, Pulmonary, Non-Tuberculous Mycobacterial Pneumonia, Lung Cancer Trial
Completed
- Tuberculosis, Pulmonary
- +3 more
- (no location specified)
Sep 3, 2019
Nontuberculous Mycobacteria in the Geneva Area (2015-2020)
Completed
- Ecology of Nontubercuous Mycobacteria
- Geneva Area
-
Geneva, SwitzerlandGeneva University Hospital
Jan 17, 2021
Pulmonary Disease, Pulmonary Infection, Non-Tuberculous Mycobacterial Pneumonia Trial
Not yet recruiting
- Pulmonary Disease
- +2 more
- (no location specified)
Apr 30, 2019
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022